Awards made during 1992-93
£73,000 over two years to Dr David I. Stott (Bacteriology & Immunology, Glasgow University) for a study of the genetic origins and control of expression of autoaggressive B-cell clones in systemic lupus erythematosus.
£60,464 to Professor Colin S. McArdle, Mr Barry Kelly & Dr Wilson J. Angerson (Surgery, Glasgow Royal Infirmary) for a two-year investigation of the detection of 'occult' liver metastases using duplex/colour Doppler ultrasonography.
£101,434 to Dr Neil P. Prentice (Brain Metabolism Unit) and Professor Eve C. Johnstone (Psychiatry, Royal Edinburgh Hosptial) for a three-year study of the early and late onset of depressive illness in the elderly.
£30,828 over two years to Dr Roger G. Sutcliffe (Genetics), Professor William R. Lee (Ophthalmology & Pathology) & Dr John G. Edwards (Cell Biology, Glasgow University) to investigate the familial and autoimmune aspects of age-related macular degeneration.
£84,827 over three years to Dr Donald Bissett (Beatson Oncology Centre, Western Infirmary Glasgow) & Dr Robert Brown (Medical Oncology, Glasgow University) to study the role of p53 in resistance of tumours to the chemotherapeutic drug, cisplatin.
£88,668 to Dr Michael W.H.Coughtrie (Biochemical Medicine), Drs David H. Edgar & John A. Mills (Obstetrics & Gynaecology, Ninewells Hospital & Medical School, Dundee) for a three-year investigation of the regulation of steroid hormone activity in the human female reproductive tract and its relationship to infertility and early pregnancy loss.
£55,280 to Dr John M.S. Bartlett, Dr D. Fenton-Lee & Professor Tim G. Cooke (Surgery, Glasgow Royal Infirmary), Dr Valerie Brunton (CRC Department for Medical Oncology) & Dr Brad Ozanne (Beatson Institute for Cancer Research, Glasgow) for a two-year study of the use of novel inhibitors of EGF receptor tyrosine kinase activity as potential therapeutic agents in the control of gastric cancer.
£105,793 over three years to Dr Anna F. Dominiczak & Professor John L. Reid (Medicine & Therapeutics, Glasgow University), Dr Marek H. Dominiczak (Biochemistry, Western Infirmary Glasgow) & Dr Christopher J.K. Packard, Professor James Shepherd & Dr Dairena Gaffney (Biochemistry, Royal Infirmary Glasgow) to investigate the biochemical, cellular and genetic characteristics of familial hypercholesterolaemia in the west of Scotland.
£81,239 to Professor Anne Ferguson (Medicine) & Dr David J. Porteous (MRC Human Genetics Unit, Western General Hospital, Edinburgh) for a three-year project involving the molecular and histopathological analysis of a mouse model of cystic fibrosis.
£54,014 over two years to Dr Donald M. Salter (Pathology, Edinburgh University) to investigate the potential of tenascin as a serological marker of arthritis and to assess its role in articular cartilage degeneration and repair.
£10,124 to Dr Brian M. Frier & Dr Petros Perros (Diabetes), Dr C. Counsell (Medical Neurology, Edinburgh Royal Infirmary) & Professor T. Wallace Macfarlane (Glasgow Dental Hospital & School) for a year-long study of altered taste sensation in Type II diabetes.
£77,596 over three years to Professor John E. Fothergill & Dr William T. Melvin (Molecular & Cell Biology) & Dr Graeme I. Murray (Pathology, Aberdeen University) for a study of the role of matrix metalloproteinases in breast tumour invasion.
£39,800 to Dr Roger W. Brown (Molecular Endocrinology) & Dr Brian R. Walker & Dr Johathan R. Seckl (Medicine, Western General Hospital Edinburgh) for a two-year project involving the isolation and molecular characterisation of 11-beta-hydroxysteroid degydrogenase Type II.
The Mrs Jean V. Baxter Medical Research Fellowship 1993-95 was awarded to Dr Karen J. Horsburgh (Wellcome Surgical Institute & Hugh Fraser Laboratories, Glasgow University) for work on protein kinase and beta-amyloid protein deposition in human head injury and stroke.
The Cruden Medical Research Scholarship 1993-94 was awarded to Dr Robert I. Cargill (Clinical Pharmacology, Ninewells Hospital & Medical School, Dundee) to study the effects of vasoactive peptides on the pulmonary vascular bed.